お知らせ
Date |
Announcement |
|---|---|
| October 1, 2020 |
Repligen and Navigo Proteins Announce Achievement of Key Milestone in Developing an Affinity Resin for the Purification of COVID-19 Vaccines. Read More |
|
June 29, 2020 |
Repligen Announces Agreement to Acquire Engineered Molding Technology. Read More |
|
April 26, 2019 |
Repligen Corporation Announces Agreement to Acquire Process Analytics Innovator C Technologies. Read More |
|
Septermber 4, 2018 |
Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-Generation Perfusion-Enabled Bioreactors. Read More |
|
June 28, 2018 |
Repligen Selects Purolite Life Sciences as Commercial Partner for New High Performance Ligand. Read More |
|
June 27, 2018 |
Repligen Announces Agreement with Navigo Proteins for the Exclusice Co-Development of Next Generation Affinity Ligands. Read More |
|
June 23, 2017 |
Repligen Corporation and Spectrum Inc. to Join Forces. Read More |
|
December 15, 2016 |
Repligen acquires TangenX Technology Corporation. Read More |
|
October 4, 2016 |
Repligen Launches Single-Use XCell™ ATF System for Bioprocess Intensification. Read More |
|
April 4, 2016 |
Repligen acquires Atoll GmbH. Read More |
最近のニュース
Date |
Title |
Publication |
|---|---|---|
| October 8, 2020 | Dan Stanton BioProcess International |
|
| September 1, 2020 | Gareth John Macdonald GEN |
|
| July 1, 2020 |
Repligen boosting single-use portfolio with Engineered Molding Technology buy |
BPI Staff BioProcess International |
| February 24, 2020 | Dan Stanton BioProcess International |
|
| October 1, 2019 | Using Alternating Tangential Flow with Fed-Batch Cultures |
GEN |
| August 12, 2019 | Samsung BioLogics Implements Large Scale N-1 Perfusion for Commercial Application. Samsung BioLogics’ cell culture technique to cut production life by 30% Samsung BioLogics Implements Large Scale N-1 Perfusion for Commercial Application Samsung BioLogics implants cell-culturing tech |
Samsung Biologics Pulse News Yahoo News Korea Biomed |
| May 20, 2019 | OPUS focus: Repligen expands to support chromatography demand | Dan Stanton BioProcess International |
| August 21, 2018 |
Fortune Top 100 Fastest-Growing Companies in 2018 |
Fortune Inc. |
Press Contact
Sondra Newman
Senior Director, Investor Relations
Phone: 781.250.0111
Toll-free: 800.622.2259
Fax: 781.250.0115